SI-BONE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SI-BONE, INC. (SIBN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-04
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 0.00 shares.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-04 | 0.00 shares 10-Q · filed 2026-08-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-24 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-04 | 0.00 shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-04 | 0.00 shares 10-Q · filed 2025-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-04 | 0.00 shares 10-Q · filed 2026-08-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-04 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-24 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-24 | 0.00 shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-10 | 0.00 shares 10-Q · filed 2025-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-05 | 0.00 shares 10-Q · filed 2025-08-05 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-24 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-06 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-24 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-24 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-24 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-24 | 0.00 shares 10-K · filed 2026-02-24 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-06 | 0.00 shares 10-Q · filed 2024-08-06 | 0.00 shares derived: sum of 3 quarters · filed 2025-02-25 | 0.00 shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-25 | 0.00 shares derived: sum of 3 quarters · filed 2025-02-25 | 0.00 shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-25 | 0.00 shares derived: sum of 3 quarters · filed 2025-02-25 | 0.00 shares 10-K · filed 2025-02-25 |
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-07 | 0.00 shares 10-Q · filed 2023-11-07 | 0.00 shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2023-08-08 | 0.00 shares 10-Q · filed 2023-08-08 | 0.00 shares derived: sum of 3 quarters · filed 2023-08-08 | 0.00 shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-02 | 0.00 shares derived: sum of 2 quarters · filed 2023-05-02 | 0.00 shares derived: sum of 3 quarters · filed 2023-05-02 | 0.00 shares derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-02 | 0.00 shares derived: sum of 3 quarters · filed 2023-03-02 | 0.00 shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2022-11-08 | 0.00 shares 10-Q · filed 2022-11-08 | 0.00 shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-09 | 0.00 shares 10-Q · filed 2022-08-09 | 0.00 shares derived: sum of 3 quarters · filed 2022-08-09 | 0.00 shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-10 | 0.00 shares derived: sum of 2 quarters · filed 2022-05-10 | 0.00 shares derived: sum of 3 quarters · filed 2022-05-10 | 0.00 shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-01 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-01 | 26.24K shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2021-11-09 | 26.24K shares 10-Q · filed 2020-11-03 | 26.24K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2021-08-04 | 26.24K shares 10-Q · filed 2020-08-04 | 26.24K shares derived: sum of 3 quarters · filed 2021-08-04 | 34.58K shares derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | 26.24K shares 10-Q · filed 2020-05-05 | 26.24K shares derived: sum of 2 quarters · filed 2021-03-10 | 34.58K shares derived: sum of 3 quarters · filed 2021-03-10 | 196.62K shares derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | 8.34K shares derived: sum of 2 quarters · filed 2021-03-10 | 170.38K shares derived: sum of 3 quarters · filed 2021-03-10 | 638.98K shares 10-K · filed 2021-03-10 |
| 2019-09-30 | 8.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 170.38K shares derived: sum of 2 quarters · filed 2019-11-12 | 638.98K shares 10-Q · filed 2019-11-12 | 665.28K shares derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-06-30 | 162.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 630.64K shares 10-Q · filed 2019-08-07 | 656.94K shares derived: sum of 3 quarters · filed 2020-03-11 | |
| 2019-03-31 | 468.60K shares 10-Q · filed 2019-05-09 | 494.90K shares derived: sum of 2 quarters · filed 2020-03-11 | ||
| 2018-12-31 | 26.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | 100.08K shares 10-K · filed 2020-03-11 | ||
| 2018-09-30 | 73.78K shares 10-Q · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |